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The sensitive detection of human cells in immunodeﬁcient rodents is a prerequisite for the monitoring of micrometastasis of
solid tumours, dissemination of leukaemic cells, or engraftment of haematological cells. We developed a universally applicable
polymerase chain reaction method for the detection of a human-speciﬁc 850-bp fragment of the a-satellite DNA on human
chromosome 17. The method allows the detection of one human cell in 10
6 murine cells and could be established as both, a
conventional DNA polymerase chain reaction-assay for routine screening, and a quantitative real-time polymerase chain
reaction-assay using TaqMan-methodology. It was applied to the following xenotransplantation systems in SCID and NOD/
SCID mice: (1) In a limiting dilution assay, cells of the MDA-MB 435 breast carcinoma were injected into the mammary fat
pad of NOD/SCID mice. It could be shown that 10 cells mouse
71 were sufﬁcient to induce a positive polymerase chain
reaction signal in liver and lung tissue 30 days after transplantation as an indicator for micrometastasis. At this time a palpable
tumour was not yet detectable in the mammary fat pad region. (2) Cells of a newly established human acute lymphatic
leukaemia were administered intraperitoneally to SCID mice. These cells apparently disseminated and were detectable as early
as day 50 in the peripheral blood of living mice, while the leukaemia manifestation was delayed by day 140. (3) In a
transplantation experiment using mature human lymphocytes we wanted to standardise conditions for a successful survival of
these cells in NOD/SCID mice. It was established that at least 5610
7 cells given intravenously were necessary and that the
mice had to be conditioned by 2 Gy body irradiation to get positive polymerase chain reaction bands in several organs. (4)
Engraftment studies with blood stem cells originating from cytapheresis samples of tumour patients or from cord blood were
undertaken in NOD/SCID mice in order to deﬁne conditions of successful engraftment and to use this model for further
optimisation strategies. The polymerase chain reaction method presented allowed a reliable prediction of positive engraftment
and agreed well with the results of immunohistochemical or FACS analysis. All together, the polymerase chain reaction
method developed allows a sensitive and reliable detection of low numbers of human cells in immunodeﬁcient hosts. In
combination with real-time (TaqMan) technique it allows an exact quantiﬁcation of human cells. As this method can be
performed with accessible material of living animals, follow up studies for the monitoring of therapeutic interventions are
possible in which the survival time of mice as evaluation criteria can be omitted.
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The detection of human cells in a murine tissue is a frequently
arising problem after xenotransplantation of normal or malignant
cells. The formation of micrometastases of solid tumours, the
dissemination of leukaemia cells or the engraftment potential of
haematopoietic cells are examples for which a sensitive proof of
the human-speciﬁc origin of cells is necessary to address biological,
diagnostic or therapeutic questions.
In literature, for that purpose tissue-(cytokeratins) or tumour
associated markers like mucins (Finn et al, 1995) or adhesion
molecules (Giavazzi et al, 1994) are described. Also human-speciﬁc
surface markers like HLA-DR (Goan et al, 1999) or human endo-
genous retroviral sequences (Ailles et al, 1999) are used. Others,
artiﬁcially transfected cells with marker genes like lac Z (Hayashi
et al, 1996; Kru ¨ger et al, 1999) or green ﬂuorescent protein (Yang
et al, 2000) for a detection of the speciﬁc gene product in the in
vivo xenotransplantation system.
These methods are at least partially hampered by the fact that
tumour markers are only (over-) expressed in a certain proportion
of known malignancies. Immunohistochemical methods for the
detection of surface markers are relatively insensitive and difﬁcult
to standardise. Furthermore, the use of artiﬁcial markers is
frequently restrained by the low transfection efﬁcacy of the cells.
Therefore, we decided to develop a sensitive PCR assay which is
universally applicable either for the detection of human cells in
murine blood and organs or for a quantiﬁcation of such cells via
real-time (TaqMan) PCR. We targeted for that purpose a highly
repetitive a-satellite DNA sequence of the centromer region of
human chromosome 17 with primers which were speciﬁcally modi-
ﬁed by us according to Warburton et al (1991). The sensitivity and
speciﬁcity of that method was investigated and used for: (i) the
detection of micrometastases of a human breast carcinoma xeno-
graft; (ii) the estimation of dissemination of a human acute
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www.bjcancer.comlymphatic leukaemia (ALL) model; (iii) the proof of distribution of
mature lymphocytes and (iv) the evaluation of the engraftment
potential of human blood stem cells.
MATERIALS AND METHODS
Extraction of DNA
Genomic DNA of mouse blood and organs was extracted using the
QiaAmp blood and tissue kit respectively (Qiagen, Hilden,
Germany). Brieﬂy, the DNA of lysed cells was adsorbed onto a
silica matrix, washed and eluted with QIAamp elution buffer by
centrifugation.
Conventional DNA PCR
The presence of human-speciﬁc DNA within the blood and organs
of transplanted mice was conﬁrmed by polymerase chain reaction
(PCR) amplifying an 850-bp fragment of the a-satellite region of
the human chromosome 17 using primers corresponding to the
primer pair 17a1/17a2 as described by Warburton et al (1991).
The primers were elongated to 25 nucleotides each for use at high-
er annealing temperatures. The sequences are shown in Table 1.
For PCR, the AmpliTaq-Gold polymerase and related reagents
from Perkin Elmer (Applied Biosystems GmbH, Weiterstadt,
Germany) were used. The PCR reaction mixture contained
200 mM each of the respective nucleotides, 250 nM of each primer,
2m M MgCl2, and 250 ng of genomic DNA template. Following an
initial DNA denaturation and Taq activation at 948C for 10 min,
35 1-min cycles of denaturation at 948C and annealing/extension
at 608C were performed followed by a ﬁnal elongation step at
728C for 10 min. Ampliﬁed DNA fragments were electrophoresed
through 1.75% agarose gels and subsequently visualised through
ultraviolet light after staining with ethidium bromide. Genomic
DNA samples from both a human breast carcinoma line (MaCa
3366) as a positive control and NOD/SCID mouse liver tissue as
a negative control were processed in parallel. Routinely used
PCR was evaluated by scoring band intensities expressed by one
to three plus. One plus corresponded to very weak bands and three
plus corresponded to very intense bands comparable to that of the
positive control with 100% human cells.
Quantitative real-time (TaqMan) PCR
In parallel, we developed a TaqMan-chemistry based real-time PCR
using an optimised primer/probe-combination, which effectively
ampliﬁes a shorter (467 bp) fragment of the same a-satellite-
DNA-region (Table 1). The exonuclease probe was 5'-labelled with
the reporter ﬂuorescent dye FAM (6-carboxy-ﬂuoresceine) and
carried the non-ﬂuorescent quencher dye TAMRA. Probe extension
during PCR was blocked by a 3'-phosphate.
The standardised PCR was performed in a Perkin Elmer 7700
Sequence Detection System (TaqMan) in 96-well microtiter plates
with a ﬁnal volume of 50 ml using similar conditions as for the
conventional PCR described above. Additionally, the PCR-Mix
contained 10 nM of the TaqMan-Probe. A total of 45 cycles was
performed without a ﬁnal elongation step. Each sample was tested
twice in parallel. Serial dilution steps of human mammary carcino-
ma cells (MCF-7) in mouse ascitis cells (P388) served to construct
the TaqMan-calibration curves. These control cells were obtained
from in vivo-tumour lines established and permanently passaged
in our laboratory.
Experimental animals
For the in vivo experiments immunodeﬁcient SCID or NOD/SCID
mice (6–8 weeks of age) were used. While SCID mice lack mature
B- and T-lymphocytes due to a recombinase gene deﬁciency
(Bosma et al, 1983) NOD/SCID mice are additionally characterised
by a deﬁcit in NK-cells and functioning macrophages (Shultz et al,
1995). Balb/c-SCID mice were purchased from Bundesgesundheit-
samt (Berlin, Germany) NOD/SCID mice from Jackson
Laboratories (Bar Harbour, USA).
All mice were held under sterile and standardised conditions (208C
room temperature, 50% relative humidity, 12 h-light-dark rhythm)
in laminar ﬂow shelves with autoclaved food and bedding (Sniff,
Soest, Germany) and acidiﬁed tap water (pH 4) ad libitum. All mice
were tested for leakiness and only mice with murine IgG levels below
100 ng ml
71 serum were used for the experiments. All experiments
were performed according to the German Animal Protection Law
and with permission from the responsible local authorities.
Detection of micrometastases
Cells of the human breast carcinoma MDA-MB 435 were taken
from cell culture ﬂasks and admixed with matrigel (Basement
Membrane Matrix, Becton Dickinson, Bedford, USA) shortly
before injection into the mammary fat pad (mfp) of female
NOD/SCID mice. Six animals each received 10
6 to 1 cell in a log
10 dilution assay. Once per week tumour size was measured with
a calliper-like instrument and tumour volumes (v=(width
2×
length)/2) were calculated. Further, blood was taken from the tail
vein once per week.
After 4 weeks mice were sacriﬁced, liver, lung and tumour from
the mfp area were taken and stored at 7808C for PCR analysis.
Leukaemic dissemination
Female Balb/c-SCID mice (ﬁve per group) received 10
2,1 0
4 or 10
6
cells of a human paediatric ALL (ALL-SCID 2, Fichtner et al, 1999)
intraperitoneally (i.p.). Every 2–3 weeks blood was taken from the
tail vein and stored for PCR analysis. Mice were checked at least
twice per week for leukaemia development. Body weight was
measured once per week and related to the initial value (body
weight change, BWC) in per cent. The mice were sacriﬁced at
moribund stage and gross examined.
Distribution of lymphocytes
Three female NOD/SCID mice per group received 5610
7,1 610
7 or
0.5610
7 lymphocytes from a buffy coat after Ficoll gradient separa-
tion (Lymphocyte separation medium, Life Technologies, Eggenstein,
Germany). The cell mixture contained 5% CD4+, 5% CD8+, 7%
CD56+, 10% HLA-DR+ cells as determined by FACS analysis.
The lymphocytes were admixed with 10 U ml
71 heparin in
order to prevent aggregation and injected intravenously (i.v.) into
the tail vein. Half of the mice received a total body irradiation of
2G y (
137Cs source) 24 h before lymphocyte administration in
order to disrupt remaining circulatory macrophages in the circula-
tion. After 4 weeks mice were sacriﬁced and different organs were
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Table 1 Oligonucleotides and probes used for PCR
Name 5'?3' sequence Localisation
d
Cr17_1a
a GGG ATA ATT TCA GCT GAC TAA ACA G 15..39
Cr17_2b
b TTC CGT TTA GTT AGG TGC AGT TAT C 867..891
Cr17_4b
c AAA CGT CCA CTT GCA GAT TCT AG 472..494
TMsat_probe 6FAM-CAC GTT TGA AAC ACT CTT 109..137
XT TTG CAG GATC p (X=Tamra)
aForward primer;
breverse primer for the conventional PCR;
creverse primer for
TaqMan PCR;
dnucleotide positions correspond to the sequence HSSATA17, Gene-
Bank Acc.-No. 13882; further explanations are given in the text.
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disease (GVHD) was diagnosed by the appearance of rufﬂed fur,
an icteric view of the skin and signs of inﬂammation in the head
region. Livers of those mice were additionally examined by a
pathologist for GVHD symptoms.
Engraftment of blood stem cells
Mononuclear cells (MNC) originating from cord blood or from
peripheral blood after stem cell mobilisation were injected i.v. into
pre-irradiated (2 Gy) female NOD/SCID mice (2–5 per group).
CD34 positive progenitors were obtained by magnetic separation
as described elsewhere (Goan et al, 1996). The mice additionally
received a co-transplant consisting of a rat ﬁbroblast cell line stably
transfected with the human interleukin-3 gene in order to supple-
ment a species-speciﬁc haematopoietic growth factor (Goan et al,
1996). After at least 5 weeks the murine blood was analysed for
human DNA. In the case of a positive PCR-signal mice were sacri-
ﬁced 2–3 weeks later. Human haematopoietic cells (CD45+, HLA-
I+) were analysed by ﬂow cytometry (FACS) or immunohisto-
chemistry (IH); for details see Goan et al (1996).
RESULTS
Sensitivity and speciﬁcity of PCR method
Figure 1 shows that at least a rough visual semi-quantitative
evaluation of dilution mixtures of human in murine cells is possi-
ble by conventional DNA-PCR. While the murine P388 lymphatic
leukaemia revealed no positive signal, as few as one human MCF-7
cell (breast carcinoma line) in 10
6 of mouse cells was detectable.
However, as our dilution experiments showed, the PCR method
with 35 cycles seemed to reach a plateau phase. The differences
between band intensities of logarithmic dilution steps were too
small to perform a reliable densitometric analysis (data not
shown). In contrast, the use of lower cycle numbers allowed a
more reliable evaluation, but caused a disappearance of weak
bands. Thus, for a routine screening we decided to perform a visual
subjective estimation of band intensities characterised by one to
three plus.
TaqMan assay for real-time quantiﬁcation of human DNA
Since certain xenotransplantation experiments require an exact
quantiﬁcation of human cells in mouse organs, we developed in
parallel a TaqMan-chemistry based real-time PCR approach ampli-
fying a smaller fragment of the same genome localisation and using
similar reaction and cycle conditions. Serial dilutions of human
MCF-7 cells in mouse P388 cells tested with each PCR reaction
served to construct the TaqMan-calibration curves. We always
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Figure 1 Human speciﬁc DNA-PCR of an a-satellite sequence of chro-
mosome 17 used as a screening assay for human cells in the mouse. Sensi-
tivity of the PCR method proved by logarithmic dilution steps of human
MCF-7 cells in mouse P388 ascitis cells.
Figure 2 TaqMan created calibration curve using a dilution series of human MCF-7 cells in mouse P388 ascitis cells as processed with each TaqMan PCR.
CT describes the threshold cycle number at which ﬂuorescence exceeds 10-fold the standard deviation of the ﬂuorescence detected during PCR cycles 3–
15. This calibration curve serves to calculate the amount of human DNA reﬂecting the number of human cells.
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British Journal of Cancer (2002) 87(11), 1328–1335 ã 2002 Cancer Research UKobtained a linear correlation between DNA-amount, respectively
cell numbers, and the CT values over the whole detection range
from 50 to 0.001% human cells (with some slight deviations in
the highest 100% and the lowest 0.0001% dilution step). Calibra-
tion results are presented in Figure 2. Figure 3 shows the
TaqMan results of mouse liver and lung of three animal groups
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Figure 3 Example for the detection of micrometastases in mouse liver and lung in the MDA-MB 435 xenotransplantation experiment performed by both
the conventional DNA PCR and the quantitative real-time PCR. The inoculation of 100 (A), 10 (B) and 1 (C) human tumour cells per mouse correlated
with a decrease of the PCR signal in the organs (same as experiment documented in Table 2).
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(11), 1328–1335of the micrometastasis experiment with the human breast carcino-
ma xenograft MDA-MB 435 as described below (Table 2). The
columns are related to the agarose gel bands of ampliﬁcation
products and the resulting visual estimation of band intensities
of corresponding samples as obtained by conventional PCR.
Detection of micrometastases
The human breast carcinoma line MDA-MB 435 is highly metasta-
sising after orthotopic inoculation into the mfp of
immunodeﬁcient mice (Price et al, 1990). Lung and lymph node
metastases are usually macroscopically detectable after a relatively
long growth period when the primary tumour reaches a volume
of more than 1.5 cm
3.
In our assay system (Table 2 and Figure 3) only 10 cells per
mouse were sufﬁcient to detect human DNA in lung and liver
of mice, while at that point of time (30 days after inoculation)
no palpable tumour in the mfp-region was detectable. Higher cell
numbers led to an increase in primary tumour size and a corre-
sponding magniﬁcation of the PCR signal. Surprisingly, at no
time point human DNA as indicator for circulating tumour cells
could be found in the murine blood. This suggests either a predo-
minant lymphogenic pathway of metastasis or indicates that cell
numbers in circulation were below the detection limit of the assay.
The PCR method presented here allows a very sensitive detection
and quantiﬁcation of micrometastases. It can be taken as surrogate
marker for the monitoring of response of therapeutic interven-
tions.
Leukaemic dissemination
Table 3 shows the results of blood analysis of SCID mice at
several time points after inoculation of cells of a paediatric
leukaemia, ALL-SCID 2. While at day 50 transiently human
DNA was detected in ﬁve out of ﬁve mice receiving 10
6 cells,
three out of ﬁve mice with 10
4 and only one out of ﬁve mice
with 10
2 cells, at later time points (day 97) a positive PCR signal
was only obtained in three out of ﬁve mice at the highest cell
dose. At a delayed time, after 140 days, when the animals were
sacriﬁced due to a moribund stage only in those mice with detec-
tion of human DNA at an advanced stage the leukaemia became
manifest. The leukaemia development in the peritoneum was
accompanied by a concomitant increase in body weight. It can
be concluded that the determination of human DNA by the
PCR method presented here, allows an early evaluation of leukae-
mic dissemination before manifestation of the disease. This
enables the initiation of therapeutic interventions in the xenograft
system at a stage being comparable with minimal residual disease
in patients.
Distribution of lymphocytes
The distribution pattern and survival rate of mature lymphocytes
after i.v. injection into NOD/SCID mice can be taken from Table
4. At least 10
7 cells had to be inoculated to obtain a positive
PCR signal in bone marrow, thymus, lymph node and lung, while
the ﬁve-fold cell number apparently led to a broad distribution of
lymphocytes to all tissues analysed. There was a clear difference
between irradiated and non-irradiated mice indicating that a
sublethal pre-irradiation leading to a long-standing depletion of
macrophages (data not shown) is a precondition for a survival of
i.v. inoculated mature lymphocytes.
The positive take rate of 5610
7 or 10
7 lymphocytes was accom-
panied by the appearance of GVHD symptoms in one out of three
or two out of three mice, respectively.
Our results conﬁrm the limited survival potential of mature
lymphocytes in the conditioned murine host. Oppositely, the
PCR method enables the evaluation of lymphocyte distribution
and survival in experiments investigating immunotherapeutic
approaches against cancer.
Engraftment of blood stem cells
The administration of cord blood mononuclear or CD34 positive
(490% of cell mixture) cells to NOD/SCID mice led in two out
of three independently performed experiments (Table 5 I and II)
to positive PCR signals in the blood of mice at 7–11 weeks after
transplantation. When blood and bone marrow of those mice
were analysed for haematopoietic cells (CD45, HLA-I) by FACS
and IH a high percentage of human cells could be found, espe-
cially in the bone marrow (Figures 4 and 5). In blood, 0.9 to
6.6% human CD45 positive cells were found conﬁrming the
PCR results obtained several weeks before. In one example of
experiment II, after 7 weeks no human DNA in the blood was
detected. Testing the same mice after 11 weeks, a positive signal
was obtained. That suggests a relatively long time period being
necessary before establishment of a human haematopoiesis, lead-
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Table 2 Detection of micrometastases
Cell
Tumour
volume mm
3 PCR result
number (d30) Liver Lung mfp area Blood
10 + 77 7
10 0 ++ ++ (+) 7
10
2 6+5+ + + + + +7
10
3 200+99 ++ ++ ++ 7
10
4 402+153 ++ ++ ++ 7
10
5 914+294 ++ ++ +++ 7
10
6 1183+360 ++ ++ +++ 7
Six female NOD/SCID mice per group were inoculated into the mammary fat pad
(mfp) with the indicated cell numbers of the human MDA-MB 435 breast cancer
carcinoma admixed with matrigel. Blood was taken once per week. After 30 days
mice were sacriﬁced and their liver, lung and mfp-area were analysed for human
DNA. The size of the primary tumour was measured with a caliper-like instrument
and the volumes were calculated.
Table 3 Leukaemic dissemination – cell dose dependency
Cell
PCR result
on day Body weight
gain (%)
Leukaemia
development
Group Mouse number 14 35 50 97 d 140 on day 140
A1 1 0
6 77 + +++ 29 +
2 77 + +++ +
3 77 ++ + +
4 77 + 77
5 77 + 77
B1 1 0
4 77++ 7 20 7
2 777 7 7
3 777 7 7
4 77 + 77
5 77 + 77
C1 1 0
2 777 7 16 7
2 777 7 7
3 77 + 77
4 777 7 7
5 777 7 7
Five Balb/c-SCID mice per group obtained 10
6,1 0
4,o r1 0
2 cells of the paediatric
leukaemia ALL-SCID 2 i.p. At the indicated times, blood was taken from the tail vein
and analysed for human DNA. Leukaemia development was diagnosed in sacriﬁced
mice by gross examination.
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Figure 4 FACS analysis of bone marrow of mice 12 weeks after transplantation of cord blood MNC (A) or sorted CD 34 cells (B) from experiment II,
Table 4. FL-1=CD 19
7 FITC, FL-2=CD 45
7 PE.
A B
C D
Figure 5 Immunohistochemistry of bone marrow of mice 12 weeks after transplantation of cord blood MNC (A, B) or CD 34 cells (C, D) of experiment
II (Table 4) (A, C) HLA-I positive cells; (B, D) CD45 positive cells.
Table 4 Distribution of human lymphocytes
Body
PCR results
irradiated Cell Bone Lymph
Group (2 Gy) number Blood marrow Liver Spleen Thymus node Lung Heart Stomach Gut Skin GVHD
A+ 5 ×10
7 +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 1/3
B+ 1 ×10
7 7 ++ 77 ++ + + 77 7 7 2/3
C + 0.5×10
7 777 77 7 + 77 7 7 0/3
D 7 5×10
7 7 + 77 + 7 + 77 7 7 0/3
E 7 1×10
7 777 77 7 7 777 7 0/3
F 7 0.5×10
7 777 77 7 7 777 7 0/3
Lymphocytes of a healthy donor were injected i.v. into three NOD/SCID mice per group. Mice of groups A–C were sublethally irradiated with 2 Gy. After 29 days mice were
sacriﬁced; blood, bone marrow and different organs were analysed for human DNA; mean values are presented. Graft vs host disease (GVHD) was visible by rufﬂed fur, icteric
skin and inﬂamed eyes and conﬁrmed by a pathologist.
PCR quantification of human cells in mice
M Becker et al
1333
ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(11), 1328–1335ing to a detectable number of cells in the peripheral blood of
mice.
In experiment III engraftment of CD34 cells completely failed
probably due to unsufﬁcient cell numbers. This led to completely
negative results both in PCR, in FACS and IH.
The administration of 8610
6 CD34 cells gained from peripheral
blood of patients undergoing mobilising chemotherapy (experi-
ment IV) also revealed human-speciﬁc signals in PCR which
were conﬁrmed by FACS and IH analysis of blood and bone
marrow cells. On contrary, a lower cell number of 3610
6, only
led to a positive PCR result but failed to show the presence of
human cells by FACS and IH. This emphasises the expected higher
sensitivity of the PCR method compared to the other two techni-
ques. All together, it can be concluded that the detection of human
DNA in the peripheral blood of mice xenotransplanted with
haematopoietic cells can be taken in the vast majority of cases as
an indicator for a positive engraftment.
DISCUSSION
After xenotransplantation of human cells into mice, it is frequently
necessary to detect those cells as early as possible and at a relatively
low level.
This problem for instance arises when metastasising models of
human solid tumours are used (Giavazzi et al, 1986; Fodstad et
al, 1988; Morikawa et al, 1988; Shoemaker et al, 1991) and their
growth and dissemination potential has to be evaluated for an esti-
mation of efﬁcacy of therapeutic approaches.
Even more complicated is the situation when haematological
malignancies as models in immunodeﬁcient mice are used (Uckun,
1996). Here, frequently an early diagnosis of only few disseminated
cells is warranted to start therapeutic interventions in a clinically-
related manner as early as possible and before the disease becomes
manifested and incurable.
Modern experimental gene- and immunotherapeutic approaches
against cancer occasionally use transfected or modiﬁed haematologi-
cal cells. In those pre-clinical studies it is inavoidable to characterise
thesurvival anddistribution potential of these cells(Licht et al,1998).
And last but not least, several projects deal with the engraftment
potential of blood stem cells for the enabling of high-dose-
chemotherapy protocols. Questions of interest in this area are
the potential of ex vivo-expansion protocols of CD34 positive cells
(Mo ¨best et al, 1999) or the role of stroma and endothelial cells for
the engraftment of stem cells (Goan et al, 2000).
For that purpose, the necessity arose to develop an analytical
method which is sensitive, speciﬁc and universally applicable to
detect human cells in immunodeﬁcient mice.
Shoemaker et al (1992) described the use of repetitive human
Alu DNA sequences in a dotblot assay which allowed the quantita-
tive detection of metastases of a human melanoma in several
tissues of nude mice.
We decided to develop a human speciﬁc PCR method targeting
highly repetitive sequences of the a-satellite DNA of the centromer
region of human chromosome 17. A 850 bp fragment was ampli-
ﬁed with primers which were varied according to Warburton et
al (1991). A BLAST-search of this human sequence fragment in
the EMBL rodent DNA database as well as in the ENSEMBLE
whole mouse genome browser (EBI, Hinxton, Cambridge, UK)
revealed no signiﬁcant similarity with any mouse DNA sequence.
Thus, these sequences seem to be completely absent in the mouse
genome and the method shows high speciﬁcity for human tissues
with a complete lack of positive signals for murine tissues. As
shown by logarithmic dilution series, we were able to detect one
human cell in 10
6 murine cells. However, with 35 cycles necessary
to reach the high sensitivity the method allowed only a rough
semi-quantitative estimation. Therefore, we developed in parallel
a quantitative real-time PCR approach based on TaqMan metho-
dology, targeting a smaller fragment of the same genome
localisation. The resulting standardised TaqMan assay provides
the possibility for a quantiﬁcation of human cells in the mouse
from 100% up to 0.0001% (one human cell in 10
6 mouse cells).
The method described herein was used for the detection of
micrometastases of a breast carcinoma model. It proved its high
sensitivity by detecting human DNA in lung and liver of NOD/
SCID mice after orthotopic transplantation of only 10 cells and
at an early time point when no primary tumour was palpable.
The lack of positive signal in the blood of mice even at injection
of up to 10
6 cancer cells suggests the predominance of a lympho-
genic route of dissemination leading to probably only few or
shortly surviving cells in the blood circulation.
On the contrary, the manifestation of an ALL in SCID mice
demanded at least 10
6 cells and took several months. But even in this
case, the PCR method allowed an about 50-days earlier detection of
human cells in the blood of engrafted mice. That fact makes the xeno-
transplantation model suitable for the study of minimal residual
disease andfor the early commencement of therapeutic interventions.
Similar to others (Martino et al, 1993) we also stated that the
survival of human mature lymphocytes gained from peripheral
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Table 5 Engraftment of blood stem cells
Cell Results % Human CD45 % Human CD45 % Human HLA-I
Experiment Source Cells number PCR (week) in blood
a (week) in bone marrow
a (week) in bone marrow
b (week)
I Cord blood MNC 10
7 +++ (9) 6.6 (9) 64.6 (9) n.t.
10
7 +++ (9) 1.5 (9) 17.1 (9) n.t.
II Cord blood MNC 2×10
7 ++ (7)
++ (11) 3.9 (12) 59.2 (12) 60 (12)
2×10
7 7 (7)
+++ (11) 0.9 (12) 37.8 (12) 80 (12)
CD34 10
5 ++ (7)
++ (11) 6.3 (12) 66.0 (12) 11 (12)
III Cord blood CD34 3×10
5 7 (5) 0 (7) 0 (7) n.t. (7)
7 (5) 0 (12) 0 (12) 0 (12)
7 (5) 0 (12) 0 (12) 0 (12)
IV BPC CD34 8×10
6 + (8) 1.9 (9) 34.5 (9) 15 (9)
3×10
6 + (8) 0 0 0 (9) 0 (9)
aImmunohistochemistry;
bFACS. n.t.=not tested. Blood stem cells originating from different sources (cord blood, BPC-blood progenitor cells) were injected either as mixtureo f
mononuclear cells (MNC) or enriched CD34 positive cells i.v. to sublethally irradiated (2 Gy) NOD/SCID mice (2–5 per group). At the indicated times blood was analysed for
human-speciﬁc DNA. Some weeks later mice were sacriﬁced, CD45 positive or HLA-I positive cells were determined in blood or bone marrow by ﬂow cytometry(
a)o r
immunohistochemistry (
b).
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7 cells to be trans-
planted and requiring a conditioning of mice by sublethal total
body irradiation. Those conditions have to be known for preclini-
cal studies using immunotherapeutic agents (vaccines, antibodies).
Oppositely, haematopoietic stem cells isolated from cord blood
or from cytapheresates of patients after mobilising chemotherapy
under our conditions successfully engrafted in the majority of
cases. Here, a good correlation of PCR, FACS and IH results could
be shown.
In the past, imaging techniques have been developed for detec-
tion and quantiﬁcation of tumours based on genetically engineered
tumour cells expressing reporters such as beta galactosidase, green
ﬂuorescent protein or the newly emerging technology based on
luciferase reporters (Rice et al, 2001). These methods have the rela-
tive disadvantage that they require transformation of tumour cells
with an expression vector to enable detection and in the case of
luciferase, infusion of the luciferin substrate intravenously. Such
genetic manipulation could potentially alter phenotypes of rele-
vance to experimental work. However, the imaging approaches
are relevant to the current report in that both techniques could
proﬁtably be used in concert. For example, experiments using luci-
ferase or GFP methods could be conﬁrmed and generalised using
our universally applicable PCR approach.
In summary, the PCR method described herein allows a speciﬁc
and sensitive detection of human cells in xenotransplantation
systems. The method is relatively simple, well-standardisable,
non-radioactive, and except for the technical device relatively inex-
pensive. However, because of its high sensitivity, the method
requires a very clean laboratory work to avoid any contamination
with human genomic DNA. When performed as a real-time PCR
using TaqMan methodology, it allows a reliable quantiﬁcation of
human cells in mouse organs over a wide dilution range. It can
be used as an universally applicable surrogate marker for the quan-
titative evaluation of engraftment, proliferation and dissemination
of malignant or normal cells in immunodeﬁcient hosts.
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